References(29)
[1]
W. Li, T. Yang, and C. Wang, Current status and progress of prevention and treatment of chronic obstructive pulmonary disease in China, (in Chinese), J. Chin. Res. Hosp., vol. 7, no. 5, pp. 78–84, 2020.
[2]
C. Wang, J. Y. Xu, L. Yang, Y. J. Xu, X. Y. Zhang, C. X. Bai, J. Kang, P. X. Ran, H. H. Shen, F. Q. Wen, et al., Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): A national cross-sectional study, Lancet, vol. 391, no. 10131, pp. 1706–1717, 2018.
[3]
S. Haroon, R. E. Jordan, D. A. Fitzmaurice, and P. Adab, Case finding for COPD in primary care: A qualitative study of the views of health professionals, Int. J. Chron. Obstruct. Pulmon. Dis., vol. 10, pp. 1711–1718, 2015.
[6]
A. Kaplan and M. Thomas, Screening for COPD: The gap between logic and evidence, Eur. Respir. Rev., vol. 26, no. 143, p. 160113, 2017.
[8]
D. Y. Zhang, Y. Gao, W. H. Jian, M. Yao, J. P. Zheng, and N. S. Zhong, Feasibility and suggestions on the promotion of pulmonary function test in primary health care institutions, (in Chinese), Chin. Gen. Prac., vol. 23, no. 29, pp. 3638–3643, 2020.
[9]
K. L. Hon, E. Leung, J. L. Tang, C. M. Chow, T. F. Leung, K. L. Cheung, and P. C. Ng, Premorbid factors and outcome associated with respiratory virus infections in a pediatric intensive care unit, Pediatr. Pulmonol., vol. 43, no. 3, pp. 275–280, 2008.
[10]
Y. Gao and J. P. Zheng, Develop standardized lung function training to help prevent and control chronic respiratory diseases, (in Chinese), Chin. J. Pract. Intern. Med., vol. 39, no. 5, pp. 481–484, 2019.
[11]
R. E. Jordan, P. Adab, A. Sitch, A. Enocson, D. Blissett, S. Jowett, J. Marsh, R. D. Riley, M. R. Miller, B. G. Cooper, et al., Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): A cluster-randomised controlled trial, Lancet Respir. Med., vol. 4, no. 9, pp. 720–730, 2016.
[12]
P. J. P. Poels, T. R. J. Schermer, R. P. Akkermans, A. Jacobs, M. Van Den Bogart-Jansen, B. J. A. M. Bottema, and C. Van Weel, General practitioners’ needs for ongoing support for the interpretation of spirometry tests, Eur. J. Gen. Pract., vol. 13, no. 1, pp. 16–19, 2007.
[13]
A. A. Montgomery, T. Fahey, T. J. Peters, C. Macintosh, and D. J. Sharp, Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: Randomised controlled trial, BMJ, vol. 320, no. 7236, pp. 686–690, 2000.
[14]
R. T. Sutton, D. Pincock, D. C. Baumgart, D. C. Sadowski, R. N. Fedorak, and K. I. Kroeker, An overview of clinical decision support systems: Benefits, risks, and strategies for success, NPJ Digit. Med., vol. 3, no. 1, p. 17, 2020.
[15]
D. B. Proce, D. G. Tinkelman, R. J. Nordyke, S. Isonaka, and R. J. Halbert, Scoring system and clinical application of COPD diagnostic questionnaires, Chest, vol. 129, no. 6, pp. 1531–1539, 2006.
[16]
M. Preteroti, G. A. Whitmore, K. L. Vandemheen, J. M. Fitzgerald, C. Lemière, L. P. Boulet, E. Penz, S. K. Field, S. Gupta, R. A. Mcivor, et al., Population-based case-finding to identify subjects with undiagnosed asthma or COPD, Eur. Respir. J., vol. 55, no. 6, p. 2000024, 2020.
[17]
Y. M. Zhou, S. Y. Chen, J. Tian, J. Y. Cui, X. C. Li, W. Hong, Z. X. Zhao, G. P. Hu, F. He, R. Qiu, et al., Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China, Int. J. Tuberc. Lung Dis., vol. 17, no. 12, pp. 1645–1651, 2013.
[18]
C. B. Jia, K. Huang, C. Y. Zhang, F. Fang, F. Dong, X. Y. Gu, H. T. Niu, S. W. QuMu, X. X. Ren, W. Li, et al., Status survey of the diagnosis and management ability of chronic obstructive pulmonary disease in eighty cities in China, (in Chinese), Chin. J. Clin., vol. 49, no. 6, pp. 669–671, 2021.
[21]
R. Kohavi, A study of cross-validation and bootstrap for accuracy estimation and model selection, in Proc. 14th Int. Joint Conf. Artificial Intelligence, Montreal, Canada, 1995, pp. 1137–1143.
[22]
T. Hastie, S. Rosset, J. Zhu, and H. Zou, Multi-class AdaBoost, Stat. Interface, vol. 2, no. 3, pp. 349–360, 2009.
[23]
A. K. Sahoo, C. Pradhan, and H. Das, Performance evaluation of different machine learning methods and deep-learning based convolutional neural network for health decision making, in Nature Inspired Computing for Data Science, M. Rout, J. Rout, and H. Das, eds. Cham, Switzerland: Springer, 2020, pp. 201–212.
[24]
S. Lundberg and S. I. Lee, A unified approach to interpreting model predictions, arXiv preprint arXiv: 1705.07874, 2017.
[25]
F. J. Martinez, A. E. Raczek, F. D. Seifer, C. S. Conoscenti, T. G. Curtice, T. D’Eletto, C. Cote, C. Hawkins, and A. L. Phillips, Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS), COPD, vol. 5, no. 2, pp. 85–95, 2008.
[26]
D. Kotz, P. Nelemans, C. P. van Schayck, and G. J. Wesseling, External validation of a COPD diagnostic questionnaire, Eur. Respir. J., vol. 31, no. 2, pp. 298–303, 2008.
[27]
P. S. Bakke, E. Rönmark, T. Eagan, F. Pistelli, I. Annesi-Maesano, M. Maly, M. Meren, P. Vermeire, J. Vestbo, G. Viegi, et al., Recommendations for epidemiological studies on COPD, Eur. Respir. J., vol. 38, no. 6, pp. 1261–1277, 2011.
[28]
J. G. Hansen, L. Pedersen, K. Overvad, Ø. Omland, H. K. Jensen, and H. T. Sørensen, The prevalence of chronic obstructive pulmonary disease among Danes aged 45–84 years: Population-based study, COPD, vol. 5, no. 6, pp. 347–352, 2008.
[29]
F. A. A. Mohamed Hoesein, P. Zanen, A. P. E. Sachs, T. J. M. Verheij, J. W. J. Lammers, and B. D. L. Broekhuizen, Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-dilator values?, COPD, vol. 9, no. 4, pp. 338–343, 2012.